NCT Number: NCT00257972
Study of Aripiprazole in Patients With Bipolar I Disorder
The purpose of this research study is to compare the efficacy of aripiprazole with placebo in combination with lithium or valproate monotherapy, in the treatment of bipolar I patients with manic or mixed episodes.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Local Institution, Epping, Victoria, Australia
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Clinical diagnosis of bipolar I disorder, manic or mixed episode
Exclusion criteria
- First manic or mixed episode
- Allergic, intolerant, or unresponsive to lithium and valproate or to aripiprazole
- Participation in a previous clinical trial within the past month or ever participated in a trial with aripiprazole
Treatment and study plan
Primary outcomes
-
Change from baseline to endpoint in a mania rating scale
Secondary outcomes
-
Response rate and Clinical Global Impression Scale at endpoint
Sponsors and collaborators
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Collaborators
- Otsuka America Pharmaceutical
Registry information
Official study title
Efficacy of Aripiprazole in Combination With Valproate or Lithium in the Treatment of Mania in Patients With Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy
Important dates
- Study start
- 2004
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Nov 24, 2005
- Registry last updated
- Nov 8, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder
NCT06365021
Bipolar Disorder, Bipolar and Related Disorders
São Paulo, Brazil
View Trial DetailsBezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
NCT02481245
Bipolar Disorder, Bipolar and Related Disorders
Boston, Massachusetts, United States
View Trial DetailsLithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsEffects of Theta Burst Stimulation on the Brain, Behavior, and Clinical Symptoms in Adults With Bipolar Disorder
NCT04696471
Bipolar Disorder, Bipolar and Related Disorders
Pittsburgh, Pennsylvania, United States
View Trial Details